The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 3
- 主要终点
- Experiential understanding of remifentanil-assisted labor from the perspectives of mothers
研究概览
简要总结
Background:
Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark.
Objective:
This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives.
Methods:
A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
详细描述
Background:Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective:This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on semi-structured interviews with women who gave birth using remifentanil and the midwives involved in their care. The analysis will be a thematic content analysis. All Danish or English speaking labouring women and midwifes at North Zealand hospital giving birth/attending birth with remifentanil for labour pain are eligible to be included during the study period. After written consent the interview will be conducted 4-10 days after the birth.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women in labor aged 18 years or older who receive remifentanil for pain relief during childbirth at the labor ward in Hillerød.
- •Midwives who participate in childbirths where remifentanil is used as pain relief.
- •Exclusion Criteria
- •Women in labor who do not speak Danish or English.
排除标准
- 未提供
结局指标
主要结局
Experiential understanding of remifentanil-assisted labor from the perspectives of mothers
时间窗: Interviews conducted within 4-10 days postpartum
The co-primary outcome is the in-depth qualitative description of how women experience the use of remifentanil for labor pain relief. The outcome will be derived through thematic analysis of semi-structured interview data, aiming to identify key themes related to pain relief, side-effects, safety, communication, autonomy, and overall birth experience. No quantitative scale will be used.
Experiential understanding of remifentanil-assisted labor from the perspectives of midwives
时间窗: Time Frame: Interviews conducted within 4-10 days postpartum
Description: The co-primary outcome is the in-depth qualitative description of how midwifes experience the use of remifentanil for labor pain relief. The outcome will be derived through thematic analysis of semi-structured interview data, aiming to identify key themes related to pain relief, side-effects, safety, communication, autonomy, and overall birth experience. No quantitative scale will be used.
次要结局
未报告次要终点
研究者
Patricia Duch
M.D. Consultant, obstetric anaesthetist
Nordsjaellands Hospital